Piramal Healthcare, engaged in the manufacturing and sale of own and traded bulk drugs and formulations, has reported 17.72 per cent fall in consolidated net profit at Rs 59.87 crore during the third.
Explore Business Standard
Explore Business Standard
Don’t miss the latest developments in business and finance.
Piramal Healthcare, engaged in the manufacturing and sale of own and traded bulk drugs and formulations, has reported 17.72 per cent fall in consolidated net profit at Rs 59.87 crore during the third.
First Published: Jan 23 2009 | 12:00 AM IST